Our story

A question
became a company.

Four founders, one stubborn question, and the realization that the most life-saving device in modern medicine fails the people it's meant to save, every single day.

Why are EpiPens so inconvenient and easy to forget, when forgetting one is the difference between a normal afternoon and a hospital bed?

, The question that started EpiSafe

Chapter 01 · The realization

The treatment exists.
The device fails it.

The EpiPen has barely changed since 1987. Six inches long. Awkward to pocket. Designed to live in a backpack that you don't always grab.

So the data ends up where you'd expect: 56% of people prescribed an EpiPen don't carry one. 225 deaths a year from anaphylaxis in the U.S. $33 billion a year in direct medical costs from severe allergic reactions. And too often, the difference between a scare and a tragedy is simply whether the device was on you , or left on a kitchen counter.

Anaphylaxis can kill in minutes. The device meant to stop it shouldn't have a "but I left it at home" failure mode.

Sources: Allergy & Asthma Network (2026); ACAAI.

The traditional EpiPen, six inches long
Chapter 02 · The approach

Not a smaller EpiPen.
A rebuilt one.

Every part inside an auto-injector was designed around a six-inch tube. We didn't try to shrink it , we redrew the geometry, simulated the fluid dynamics, and engineered for a dose equivalent to a standard intramuscular injection , now being validated in bench testing.

Then we did the harder part: we put it in a phone case. The device people carry 100 times a day now carries the device that saves their life.

EpiSafe phone case prototype held in hand at Demo Day
Chapter 03 · The work

Nine months in.
Patent pending.

Computer-simulated fluid dynamics for the modified delivery path. Custom mechanical components designed to fit the case form factor without compromising spring force. Drop, temperature, and wear testing in the conditions phones already survive.

We've filed a provisional patent on both the utility and the design. Next: FDA pre-submission, formal trials, and manufacturing partnerships. We're not running a sprint, we're building something people will trust with their lives.

Internal mechanism prototype, redesigned cartridge, spring assembly, and orange release frame
In the wild
EpiSafe team accepting an award at WPI Demo Day 2025
Sep 2025 WPI Demo Day
Founder iterating on a prototype in the lab
In the lab Working through a prototype iteration

A treatment you don't carry
is no treatment at all.

The team

Four founders.
One mission.

A team built across operations, science, design, and research, meeting at the intersection of medical rigor and product obsession.

Aaryan Panchal

Aaryan Panchal

CHIEF EXECUTIVE OFFICER

Leads strategy and operations. Owns the path from prototype to FDA submission and brings the team together around a single, uncompromising mission: get epinephrine into pockets.

Joshua Kashambala

Joshua Kashambala

CHIEF OPERATING OFFICER

Runs day-to-day operations and partnerships. Has spent the last nine months turning the engineering pipeline, regulatory roadmap, and supply chain from spreadsheets into a working plan.

Ethan Takvorian

Ethan Takvorian

CHIEF TECHNICAL OFFICER

Owns industrial design and the digital product. Responsible for every line, curve, and pixel that makes EpiSafe feel less like a medical device and more like something you actually want to carry.

Khushal Sharma

Khushal Sharma

CHIEF RESEARCH OFFICER

Leads product research by gathering user feedback, identifying safety risks, and making sure EpiSafe solves a real, validated need.

Want to be part of it?

We're early. We're moving fast. And we'd love to hear from anyone who can help us get there.

See where we are → hello@episafe.co